查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
3D印刷醫藥品的全球市場 (2018年～2028年):技術、用途、終端用戶、地區趨勢分析、競爭市場佔有率、預測
市場調查報告書
商品編碼
1134209

3D印刷醫藥品的全球市場 (2018年～2028年):技術、用途、終端用戶、地區趨勢分析、競爭市場佔有率、預測

Global 3D Printed Drugs Market, By Technology ; By Application ; By End User ; and By Region, Trend Analysis, Competitive Market Share, and Forecast, 2018-2028
出版日期: | 出版商: Blueweave Consulting | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

全球3D印刷醫藥品的市場規模，從2021年的3億4,720萬美元，在預測期間中以16.4％的年複合成長率發展，2028年成長到9億6,570萬美元的規模。

在醫療、醫療保健領域作為積層製造3D列印的利用擴大，促進該市場的成長。還有今後數年，活用了3D列印技術的人工骨的製造擴大，預計市場成長。再加上各個的醫藥品的可用性提高，及併用藥的製造也預計促進3D印刷醫藥品的需求。

本報告提供全球3D印刷醫藥品的市場調查，市場概要，市場成長的各種影響因素分析，技術趨勢，法律制度，市場規模的變化、預測，各種區分、各地區/主要國家的明細，競爭環境，主要企業簡介等彙整資訊。

目錄

第1章 調查架構

第2章 調查手法

第3章 摘要整理

第4章 全球3D印刷醫藥品市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 技術的進步/最近的開發
  • 法律規範
  • 波特的五力分析

第5章 全球3D印刷醫藥品市場:概要

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
      • 直接寫入
      • 熔融沉積建模
      • 噴墨印刷
      • 粉床印刷
      • 立體光固成型
      • Zip Dose
    • 各用途
      • 神經
      • 整形外科
      • 聽覺輔助
      • 牙科用、醫療用植入
      • 其他
    • 各終端用戶
      • 醫院
      • 診療所
      • 研究實驗室
      • 其他
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲

第6章 北美的3D印刷醫藥品市場

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第7章 歐洲的3D印刷醫藥品市場

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第8章 亞太地區的3D印刷醫藥品市場

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第9章 南美的3D印刷醫藥品市場

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第10章 中東、非洲的3D印刷醫藥品市場

  • 市場規模、預測
  • 市場佔有率、預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第11章 競爭情形

  • 主要企業、產品的清單
  • 企業佔有率分析
  • 競爭基準:各經營參數
  • 主要的策略性展開 (M&A、聯盟等)

第12章 COVID-19:對全球3D印刷醫藥品市場的影響

第13章 企業簡介 (公司概要、財務矩陣、競爭情形、主要人力資源、主要的競爭對手、聯絡處、策略性展望)

  • Aprecia
  • Bioduro
  • Affnity
  • Acrux
  • Tvasta
  • FabRx
  • AstraZeneca
  • BV LLC
  • Biomedical Modeling Inc.
  • General Electric Company
  • 其他的主要企業

第14章 主要策略性建議

Product Code: BWC22363

Global 3D Printed Drugs Market Growing to almost Touch USD 1 billion by 2028

Global 3D printed drugs market flourishing owing to an increasing of 3D printed drugs in various industrial applications for improved product manufacturing and faster time to market.

BlueWeave Consulting, a leading strategic consulting and market research firm, estimated Global 3D Printed Drugs Market size value at USD 347.2 million in 2021. Also, BlueWeave expects the market to expand at a double-digit CAGR of 16.4% during the forecast period (2022-2028) to reach a size of USD 965.7 million by 2028. The market expansion is primarily driven by an increasing use of 3D printing as an additive in the medical and healthcare sectors. Over the next few years, it is expected that the growing trend of creating prosthetic bones utilizing 3D printing technology will benefit the growth of Global 3D Printed Drugs Market. An increasing availability of individual drugs and the production of combination medications, both of which are being fueled by 3D printing, are also forecast to drive the demand for 3D printed drugs.

Global 3D Printed Drugs Market - Technology Advancements

The main reason fueling the growth of the worldwide 3D printed drugs market is a surge in demand for instantly soluble medications that dissolve readily in the mouth. Additionally, an increasing use of 3D printing technology in the medical and healthcare sectors, raising use of personalized medications, and the creation of combination medications all contribute to the market's expansion. However, negative drug-related side effects, the use of 3D printing to create illicit substances, and a lack of government restrictions for 3D printed goods may limit the market expansion. On the other hand, improvements in healthcare infrastructure, technological breakthroughs, and increased knowledge of the benefits of these drugs, such as their rapid solubility in developing economies, are expected to create a wide range of growth prospects for the market's expansion.

Global 3D Printed Drugs Market - By Technology

In Global 3D Printed Drugs Market by technology, the zip dose market category had the highest market share in 2021. This medication technology is simple to utilize and helpful for dysphagia patients. The market is expanding as a result of the rising demand from elderly and young patients for medications that dissolve fast in the mouth. On the other hand, it is anticipated that inkjet printer technology would advance at the highest rate during the projected period. Patients use it frequently because it consistently produces 3D medications and has technological advantages over competing methods. Inkjet printing is a technique for depositing three-dimensional structures in solid dosage forms. Using different combinations of active pharmaceutical ingredients (APIs) and excipients (inks), rising epilepsy rates, ongoing 3D printing technological developments, and growing consumer awareness of this technology in developing countries are the main factors driving the market expansion.

Global 3D Printed Drugs Market - Regional Insights

North America dominates Global 3D Printed Drugs Market by regions. It leadership position can be ascribed to the rising prevalence of chronic diseases, the superior domestic healthcare infrastructure, significant R&D spending, and the region's expanding adoption of technology advancements. As a result of major technology advancements in 3D printed medicine techniques made by China and Japan, the Asia-Pacific region is forecast to record its growth at the highest rate. Furthermore, the expansion of clinical development frameworks, R&D, and healthcare infrastructure in developing countries, such as India, has set the Asia-Pacific market up for lucrative growth prospects over the course of the projected period.

Impact of COVID-19 on Global 3d Printed Drugs Market

The use of 3D printing has increased as a result of the COVID-19 outbreak. To help with the creation of medicines and other necessary products, the operational actors in the advanced manufacturing industry have introduced a number of 3D printers. Additionally, the COVID-19 pandemic's drug scarcity has drawn pharmaceutical companies' attention to the idea of using 3D printing technology to supply medications quickly.

Global 3D Printed Drugs Market - Competitive Landscape

To increase their market position, major companies, including Aprecia, Promote Biosciences, and Bioduro, in Global 3D Printed Drugs Market are employing several strategies, such as partnerships, mergers and acquisitions, geographic expansion, and strategic collaborations. For instance, CELLINK expanded its partnership with AstraZeneca in February 2020 to supply bioinks and bioprinters for the latter company's research advancements. AstraZeneca is utilizing these technologies to investigate novel disease targets.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Research
  • 2.2. Quantitative Research
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Region
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global 3D Printed Drugs Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technology Advancements/Recent Developments
  • 4.4. Regulatory Framework
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global 3D Printed Drugs Market Overview

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
      • 5.2.1.1. Direct Write
      • 5.2.1.2. Fused Deposition Modeling
      • 5.2.1.3. Inkjet Printing
      • 5.2.1.4. Powder Bed Printing
      • 5.2.1.5. Stereolithography
      • 5.2.1.6. Zip Dose
    • 5.2.2. By Application
      • 5.2.2.1. Neurology
      • 5.2.2.2. Orthopedic
      • 5.2.2.3. Hearing & Audibility Aid
      • 5.2.2.4. Dental or Medical Implants
      • 5.2.2.5. Others
    • 5.2.3. By End User
      • 5.2.3.1. Hospital
      • 5.2.3.2. Clinics
      • 5.2.3.3. Research Laboratories
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. The Asia Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. Middle East and Africa

6. North America 3D Printed Drugs Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.2. Canada

7. Europe 3D Printed Drugs Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. United Kingdom
      • 7.2.4.3. Italy
      • 7.2.4.4. France
      • 7.2.4.5. Spain
      • 7.2.4.6. Rest of Europe

8. Asia Pacific 3D Printed Drugs Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of Asia Pacific

9. Latin America 3D Printed Drugs Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.2. Mexico
      • 9.2.4.3. Rest of Latin America

10. Middle East & Africa 3D Printed Drugs Market

  • 10.1. Market Size & Forecast by Value, 2018-2028
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.2. UAE
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of Middle East & Africa

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis, 2021
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Covid-19 on Global 3D Printed Drugs Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

  • 13.1. Aprecia
  • 13.2. Bioduro
  • 13.3. Affnity
  • 13.4. Acrux
  • 13.5. Tvasta
  • 13.6. FabRx
  • 13.7. AstraZeneca
  • 13.8. BV LLC
  • 13.9. Biomedical Modeling Inc.
  • 13.10. General Electric Company
  • 13.11. Other Prominent Players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

  • Figure 1: Global 3D Printed Drugs Market Segmentation
  • Figure 2: Global 3D Printed Drugs Industry Value Chain Analysis
  • Figure 3: Global 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 4: Global 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 5: Global 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 6: Global 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 7: Global 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 8: North America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 9: North America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 10: North America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 11: North America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 12: North America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 13: Europe 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 14: Europe 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 15: Europe 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 16: Europe 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 17: Europe 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 18: Asia-Pacific 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 19: Asia-Pacific 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 20: Asia-Pacific 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 21: Asia-Pacific 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 22: Asia-Pacific 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 23: Latin America 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 24: Latin America 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 25: Latin America 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 26: Latin America 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 27: Latin America 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 28: Middle East & Africa 3D Printed Drugs Market Size, By Value (USD Million), 2018-2028
  • Figure 29: Middle East & Africa 3D Printed Drugs Market Share (%), By End User, By Value, 2018-2028
  • Figure 30: Middle East & Africa 3D Printed Drugs Market Share (%), By Technology, By Value, 2018-2028
  • Figure 31: Middle East & Africa 3D Printed Drugs Market Share (%), By Application, By Value, 2018-2028
  • Figure 32: Middle East & Africa 3D Printed Drugs Market Share (%), By Country, By Value, 2018-2028
  • Figure 33: Global 3D Printed Drugs Market Share Analysis, 2021

List of Tables

  • Table 1: Global 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 2: Global 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 3: Global 3D Printed Drugs Market Size. By Application, By Value (USD Million), 2018-2028
  • Table 4: Global 3D Printed Drugs Market Size. By Country, By Value (USD Million), 2018-2028
  • Table 5: North America 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 6: North America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 7: 28 North America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 8: 28 North America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 9: Europe 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 10: Europe 3D Printed Drugs Market Size, By Technology, By Value (USD Million), By Value 2018-2028
  • Table 11: 40 Europe 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 12: 40 Europe 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 13: Asia-Pacific 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 14: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Technology, By Value 2018-2028
  • Table 15: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 16: Asia-Pacific 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 17: Latin America 3D Printed Drugs Market Size, By End User, By Value (USD Million), By Value 2018-2028
  • Table 18: Latin America 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 19: Latin America 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 20: Latin America 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 21: Middle East & Africa 3D Printed Drugs Market Size, By End User, By Value (USD Million), 2018-2028
  • Table 22: Middle East & Africa 3D Printed Drugs Market Size, By Technology, By Value (USD Million), 2018-2028
  • Table 23: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Application, By Value 2018-2028
  • Table 24: Middle East & Africa 3D Printed Drugs Market Size (USD Million), By Country, By Value 2018-2028
  • Table 25: List of Key Players and Their Offerings
  • Table 26: Competitive Benchmarking, by Operating Parameters
  • Table 27 Aprecia Company Overview
  • Table 28 Aprecia Financial Overview
  • Table 29 Bioduro Company Overview
  • Table 30 Bioduro Financial Overview
  • Table 31 Affnity Company Overview
  • Table 32 Affnity Financial Overview
  • Table 33 Acrux Company Overview
  • Table 34 Acrux Financial Overview
  • Table 35 Tvasta Company Overview
  • Table 36 Tvasta Financial Overview
  • Table 37 FabRx Ltd Company Overview
  • Table 38 FabRx Ltd Financial Overview
  • Table 39 AstraZeneca Company Overview
  • Table 40 AstraZeneca Financial Overview
  • Table 41 BV LLC Company Overview
  • Table 42 BV LLC Financial Overview
  • Table 43 Biomedical Modeling Inc. Company Overview
  • Table 44 Biomedical Modeling Inc. Financial Overview
  • Table 45 General Electric Company Overview
  • Table 46 General Electric Company Financial Overview